Transaction Details
DeLuca Richard R., of Merck & Co., Inc. (NYSE:MRK), sold 58,185 shares of company stock on November 12, 2026, according to a Form 4 filing with the Securities and Exchange Commission.
The shares were sold at an average price of $148.01 per share, for a total transaction value of $8.6M. Following this transaction, DeLuca Richard R. still owns 112,955 shares of Merck & Co., Inc. stock.
About Merck & Co., Inc.
Merck & Co., Inc.'s stock currently trades at $143.37, giving the company a market capitalization of $248.8B.
Insider sales are common and don't necessarily indicate a bearish outlook. Executives regularly sell shares for tax planning, diversification, or personal liquidity. The key factors to watch are the size of the sale relative to the insider's total holdings, whether multiple insiders are selling simultaneously, and whether the trades occur near earnings announcements or other catalysts.
At $8.6 million, this transaction stands out as a significant commitment. Trades of this size from corporate insiders typically attract attention from institutional investors and analysts who track Form 4 filings for early signals about company direction.
Insider transaction data is reported to the SEC via Form 4 filings, typically within two business days of the trade. Investors can track insider activity alongside other metrics — such as institutional flows, short interest, and technical indicators — to build a more complete picture of market sentiment around Merck & Co., Inc.
Recent Insider Transactions at Merck & Co., Inc.
| Date | Insider | Type | Shares | Value |
| Nov 12, 2026 | DeLuca Richard R. | Sell | 58,185 | $8.6 million |
| Nov 12, 2026 | DeLuca Richard R. | Buy | 58,185 | $4.5 million |
| Nov 01, 2026 | DIAZ PAUL J | Buy | 613 | $92K |
| Sep 30, 2026 | Seidman Christine E | Buy | 56 | $8K |
| Sep 30, 2026 | Karsanbhai Surendralal Lanca | Buy | 112 | $16K |
Related Tools: Insider Trades Tracker | View MRK Stock Page
Frequently Asked Questions
What does insider insider_sell mean for Merck & Co., Inc. stock?
Insider insider_sells at Merck & Co., Inc. (NYSE:MRK) are reported to the SEC via Form 4 filings. While a single transaction doesn't predict future stock performance, patterns of insider buying can signal management confidence.
How can I track insider trades for MRK?
Monitor all insider transactions on the MRK insider trades page or the Insider Trades Tracker.